Adherence to Mass Drug Administration with Dihydroartemisinin-Piperaquine and
Adolescent
Antimalarials
/ administration & dosage
Artemisinins
/ administration & dosage
Child
Child, Preschool
Disease Eradication
/ methods
Drug Therapy, Combination
Family Characteristics
Female
Humans
Interviews as Topic
Malaria, Falciparum
/ epidemiology
Male
Mass Drug Administration
/ methods
Medication Adherence
/ psychology
Patient Acceptance of Health Care
/ psychology
Plasmodium falciparum
/ drug effects
Quinolines
/ administration & dosage
Zambia
/ epidemiology
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
4
7
2020
medline:
11
11
2020
entrez:
4
7
2020
Statut:
ppublish
Résumé
Mass drug administration (MDA) with artemisinin combination therapy is a potentially useful tool for malaria elimination programs, but its success depends partly on drug effectiveness and treatment coverage in the targeted population. As part of a cluster-randomized controlled trial in Southern Province, Zambia evaluating the impact of MDA and household focal MDA (fMDA) with dihydroartemisinin-piperaquine (DHAp), sub-studies were conducted investigating population drug adherence rates and effectiveness of DHAp as administered in clearing
Identifiants
pubmed: 32618267
doi: 10.4269/ajtmh.19-0667
pmc: PMC7416972
pii: tpmd190667
doi:
pii:
Substances chimiques
Antimalarials
0
Artemisinins
0
Quinolines
0
artenimol
6A9O50735X
piperaquine
A0HV2Q956Y
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
37-45Références
Malar J. 2014 Jan 28;13:33
pubmed: 24472156
Malar J. 2009 Nov 11;8:253
pubmed: 19906307
J Trop Med. 2015;2015:189232
pubmed: 26161095
J Infect Dis. 2016 Dec 15;214(12):1831-1839
pubmed: 27923947
Chin J Integr Med. 2009 Jun;15(3):189-92
pubmed: 19568711
PLoS Comput Biol. 2016 Nov 23;12(11):e1005192
pubmed: 27880764
Am J Trop Med Hyg. 2020 Aug;103(2_Suppl):7-18
pubmed: 32618247
BMC Res Notes. 2015 Mar 17;8:84
pubmed: 25888971
Trop Med Int Health. 2006 Aug;11(8):1157-65
pubmed: 16903879
Parasit Vectors. 2016 Jan 27;9:29
pubmed: 26813098
Trends Parasitol. 2010 Mar;26(3):119-24
pubmed: 20083436
PLoS One. 2014 Jan 20;9(1):e84555
pubmed: 24465418
J Infect Dis. 2013 Jun 1;207(11):1637-45
pubmed: 23468056
Trop Med Int Health. 2005 Feb;10(2):121-38
pubmed: 15679555
Clin Infect Dis. 2005 Aug 15;41(4):425-32
pubmed: 16028147
PLoS Negl Trop Dis. 2016 Jan 14;10(1):e0004358
pubmed: 26766287
Cochrane Database Syst Rev. 2014 Jan 20;(1):CD010927
pubmed: 24443033
Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):518-23
pubmed: 8266400
Malar J. 2006 Dec 22;5:127
pubmed: 17187673
Malar J. 2011 Aug 10;10:231
pubmed: 21827706
Am J Trop Med Hyg. 2020 Aug;103(2_Suppl):82-89
pubmed: 32618252
Malar J. 2014 Jan 28;13:32
pubmed: 24468007
Clin Microbiol Infect. 2011 Nov;17(11):1617-23
pubmed: 21951597
PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2447
pubmed: 24278486
BMC Infect Dis. 2013 Dec 20;13:598
pubmed: 24354627
PLoS One. 2009 Jul 29;4(7):e6358
pubmed: 19649267
Malar J. 2008 Oct 29;7:223
pubmed: 18959790
Malar J. 2014 Apr 07;13:138
pubmed: 24708571
Am J Trop Med Hyg. 2020 Aug;103(2_Suppl):46-53
pubmed: 32618249
Malar J. 2013 Oct 25;12:371
pubmed: 24160186
PLoS Med. 2011 Nov;8(11):e1001119
pubmed: 22087077
Trials. 2015 Aug 13;16:347
pubmed: 26268804
J Infect Dis. 2009 Aug 15;200(4):624-8
pubmed: 19591576